The World Federation of Hemophilia (WFH) is proud to announce the launch of Clinical Advances in Gene Therapy for Hemophilia, an online continuing medical education (CME) program developed in collaboration with the National Hemophilia Foundation, the European Haemophilia Consortium and Medscape Education. The program is designed for clinicians but available to everyone.
The program of five activities will cover important information on the science behind gene therapy for hemophilia, the latest safety and efficacy data from clinical trials and the potential role for gene therapy in addressing the challenges of current treatment options. Clinicians can qualify for CME credits for each activity while all learners can obtain a completion certificate, or simply use the program to enhance their knowledge of gene therapy in hemophilia.
The first two activities are now live!